# Compliance With Treatment For Patients With Hyperlipidemia

> **NCT00828945** · — · COMPLETED · sponsor: **Pfizer's Upjohn has merged with Mylan to form Viatris Inc.** · enrollment: 259 (actual)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DEVICE:** Lipid Self Test

## Key facts

- **NCT ID:** NCT00828945
- **Lead sponsor:** Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00828945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00828945, "Compliance With Treatment For Patients With Hyperlipidemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00828945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*